ArticleDiabetes, obesity & metabolism2025

The use of SGLT2 inhibitors in people with diabetes-related foot disease: A Delphi-based consensus study.

Patrick Highton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.